Jastinib Tablet
Marketer
Jasgur Life Sciences
Salt Composition
Axitinib (5mg)
Overview Jastinib Tablet
Jastinib tablets are prescribed for kidney cancer. This anti-cancer medication can be administered with or without food, ideally at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your individual needs and may adjust over time; strict adherence to the prescribed regimen is crucial. Improper usage or overdose may lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include elevated blood pressure, arthralgia, and decreased appetite. Diarrhea and dyspnea can be serious; manage these as directed by your doctor, maintaining adequate hydration. Regular blood pressure monitoring may be recommended. Report severe headache, disorientation, visual disturbances, nausea, or vomiting immediately. Prior to commencement, disclose any thyroid disorders, hepatic impairment, bleeding disorders, or concurrent infection treatments. Inform your healthcare provider of all medications you are taking, as interactions are possible. Jastinib is contraindicated during pregnancy and lactation; reliable contraception is essential for women undergoing treatment.
Uses of Jastinib Tablet
Renal cell carcinoma
Major Benefits of Jastinib Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jastinib tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Jastinib Tablet:
- High blood pressure
- Joint pain
- Loss of appetite
- Diarrhea
- Breathing problems
- Abdominal pain
- Constipation
- Cough
- Decreased appetite
- Decreased level of thyroid hormones
- Difficulty in speaking
- Dry skin
- Indigestion
- Headache
- Nausea
- Pain in extremities
- Painful blisters on hands and feet
- Protein in urine
- Rash
- Breathlessness
- Stomatitis (Inflammation of the mouth)
- Taste change
- Vomiting
How to use Jastinib Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jastinib tablets can be consumed with or without food, however, consistent timing is recommended.
How Jastinib Tablet works:
Jastinib tablets are a cancer treatment that inhibits the activity of a mutated protein responsible for cancer cell proliferation, thus hindering or delaying the growth and spread of cancerous tissue.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Jastinib Tablet presents unknown safety implications. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Jastinib tablets during pregnancy poses a known risk to the fetus. Therefore, its use is discouraged. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the inherent dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Jastinib Tablet while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Jastinib Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment can safely take Jastinib tablets without requiring any modification to the prescribed dosage.
LiverCAUTION
Patients with liver impairment should use Jastinib tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Data on Jastinib tablet use in patients with severe hepatic dysfunction is limited.
What if you forget to take Jastinib Tablet :
NA
Facts to Know About Jastinib Tablet
| Label | Value |
|---|---|
| Chemical Type | Indazole and Enzamide Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |






